A phase 1b/2 study of LEE011 in combination with binimetinib (MEK162) in patients with NRAS-mutant melanoma: Early encouraging clinical activity Meeting Abstract
| Authors: | Sosman, J. A.; Kittaneh, M.; Lolkema, Mpjk; Postow, M. A.; Schwartz, G.; Franklin, C.; Matano, A.; Bhansali, S.; Parasuraman, S.; Kim, K. |
| Abstract Title: | A phase 1b/2 study of LEE011 in combination with binimetinib (MEK162) in patients with NRAS-mutant melanoma: Early encouraging clinical activity |
| Meeting Title: | 50th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 32 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2014 May 30-Jun 3 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2014-05-20 |
| Language: | English |
| ACCESSION: | WOS:000358613204294 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2014.32.15_suppl.9009 |
| Notes: | Meeting Abstract: 9009 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
